Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Tuesday, October 27, 2020
Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On : Coronavirus Updates : NPR
Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On : Coronavirus Updates : NPR: The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on hospitalized COVID-19 patients. Researchers concluded the antibody treatment was "unlikely to help."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment